Filed: 11/14/2024ACC: 0001802630-24-000012
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 87 equity positions with a total reported market value of $1.29B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
87
Positions
$1.29B
Total AUM (reported)
114.46M
Total Shares
Allocation by class
COM$898.80M69.6%
S&P BIOTECH$88.92M6.9%
COM NEW$86.08M6.7%
SPONSORED ADR$74.02M5.7%
SP ADR REP B NVT$40.15M3.1%
COM STK$37.64M2.9%
CL A COM$21.47M1.7%
Portfolio Concentration
Top 3$228.29M17.7%
4–10$283.12M21.9%
11–25$367.33M28.4%
Rest$412.75M32.0%
Top 3 weight
17.7%
Top 10 weight
39.6%
Voting Authority Distribution
Total shares with voting rights: 114.46M
Sole
Full voting authority
114.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole87
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings87
Rows:
SPDR SER TR
SOLEShares900K
TypeSH
Market value$88.92M
6.89%
Sole
900K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares8.53M
TypeSH
Market value$80.08M
6.20%
Sole
8.53M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares2.53M
TypeSH
Market value$59.28M
4.59%
Sole
2.53M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares6.22M
TypeSH
Market value$51.90M
4.02%
Sole
6.22M
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares3.01M
TypeSH
Market value$42.14M
3.26%
Sole
3.01M
Shared
0.00
None
0.00
GRIFOLS S A
SOLEShares4.52M
TypeSH
Market value$40.15M
3.11%
Sole
4.52M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares216.98K
TypeSH
Market value$39.50M
3.06%
Sole
216.98K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares6.60M
TypeSH
Market value$37.64M
2.91%
Sole
6.60M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares101.89K
TypeSH
Market value$36.51M
2.83%
Sole
101.89K
Shared
0.00
None
0.00
SANOFI
SOLEShares612K
TypeSH
Market value$35.27M
2.73%
Sole
612K
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares11.84M
TypeSH
Market value$33.86M
2.62%
Sole
11.84M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.05M
TypeSH
Market value$33.24M
2.57%
Sole
1.05M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares704.58K
TypeSH
Market value$31.95M
2.47%
Sole
704.58K
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares686K
TypeSH
Market value$31.28M
2.42%
Sole
686K
Shared
0.00
None
0.00
ESSA PHARMA INC
SOLEShares4.29M
TypeSH
Market value$25.99M
2.01%
Sole
4.29M
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares1.34M
TypeSH
Market value$25.27M
1.96%
Sole
1.34M
Shared
0.00
None
0.00
SURMODICS INC
SOLEShares637.70K
TypeSH
Market value$24.73M
1.91%
Sole
637.70K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares1.07M
TypeSH
Market value$23.95M
1.85%
Sole
1.07M
Shared
0.00
None
0.00
10X GENOMICS INC
SOLEShares951K
TypeSH
Market value$21.47M
1.66%
Sole
951K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$21.00M
1.63%
Sole
1.09M
Shared
0.00
None
0.00
MERUS N V
SOLEShares398.32K
TypeSH
Market value$19.90M
1.54%
Sole
398.32K
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares662.33K
TypeSH
Market value$18.89M
1.46%
Sole
662.33K
Shared
0.00
None
0.00
EDAP TMS S A
SOLEShares7.31M
TypeSH
Market value$18.64M
1.44%
Sole
7.31M
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares82.75K
TypeSH
Market value$18.58M
1.44%
Sole
82.75K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.25M
TypeSH
Market value$18.57M
1.44%
Sole
1.25M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 900K | SH | $88.92M 6.89% | 900K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 8.53M | SH | $80.08M 6.20% | 8.53M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 2.53M | SH | $59.28M 4.59% | 2.53M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 6.22M | SH | $51.90M 4.02% | 6.22M | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 3.01M | SH | $42.14M 3.26% | 3.01M | 0.00 | 0.00 |
GRIFOLS S ASOLE | SP ADR REP B NVT | 4.52M | SH | $40.15M 3.11% | 4.52M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 216.98K | SH | $39.50M 3.06% | 216.98K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 6.60M | SH | $37.64M 2.91% | 6.60M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 101.89K | SH | $36.51M 2.83% | 101.89K | 0.00 | 0.00 |
SANOFISOLE | SPONSORED ADR | 612K | SH | $35.27M 2.73% | 612K | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 11.84M | SH | $33.86M 2.62% | 11.84M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.05M | SH | $33.24M 2.57% | 1.05M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 704.58K | SH | $31.95M 2.47% | 704.58K | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 686K | SH | $31.28M 2.42% | 686K | 0.00 | 0.00 |
ESSA PHARMA INCSOLE | COM NEW | 4.29M | SH | $25.99M 2.01% | 4.29M | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 1.34M | SH | $25.27M 1.96% | 1.34M | 0.00 | 0.00 |
SURMODICS INCSOLE | COM | 637.70K | SH | $24.73M 1.91% | 637.70K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 1.07M | SH | $23.95M 1.85% | 1.07M | 0.00 | 0.00 |
10X GENOMICS INCSOLE | CL A COM | 951K | SH | $21.47M 1.66% | 951K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $21.00M 1.63% | 1.09M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 398.32K | SH | $19.90M 1.54% | 398.32K | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 662.33K | SH | $18.89M 1.46% | 662.33K | 0.00 | 0.00 |
EDAP TMS S ASOLE | SPONSORED ADR | 7.31M | SH | $18.64M 1.44% | 7.31M | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 82.75K | SH | $18.58M 1.44% | 82.75K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.25M | SH | $18.57M 1.44% | 1.25M | 0.00 | 0.00 |
Page 1 of 4